Abigail Shoben, PhD

Associate Professor
Biostatistics
Center of Excellence in Regulatory Tobacco Science

Phone: 614-247-8092
Email: ashoben@cph.osu.edu

1841 Neil Ave.
249 Cunz Hall
Columbus, OH, 43210

Background

Dr. Shoben joined the CPH faculty in 2010, immediately after receiving her PhD from the University of Washington. Her research interests include clinical trial design, analysis, and ethics. She works on characterizing the robustness and limits of standard methods in novel situations, such as applying traditional group sequential designs to longitudinal clinical trials and applying traditional single group random effects models to cluster randomized trials when participants belong to more than one group.  She is also interested in statistical issues in the analysis of serum vitamin D measurements, which pose a particular challenge for analysis due to seasonal variability and the fact that this seasonal variability depends on demographic and behavioral factors. Her applied collaborations since joining faculty have included work in cardiovascular disease, health services research, tobacco control, veterinary public health, and cancer prevention.

Education

Ph.D., Biostatistics, University of Washington, 2010
MS, Biostatistics, University of Washington, 2008
M.Ed., Math, Science, and Technology Education, The Ohio State University, 2003
Sc.B., Chemistry, Brown University, 2002

Selected Publications

Shoben, AB. "The Value of Sound Research Practices Even Facing Pandemics." American Journal of Bioethics. Vol 13, no. 9 (2013): 15-17.

Rothstein, MA; Shoben, AB. "An Unbiased Response to the Open Peer Commentaries on 'Does Consent Bias Research?'" American Journal of Bioethics. Vol 13, no. 4 (2013): W1-W4.

Rothstein, MA; Shoben, AB. "Does Consent Bias Research?" American Journal of Bioethics. Vol 13, no. 4 (2013): 27-37.

Sachs, MC; Shoben, AB; Levin, GP; et al. "Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis." American Journal of Clinical Nutrition. Vol 97, no. 6 (2013): 1243-1251.

Shoben, AB; Kestenbaum, B; Levin, G; et al. "Seasonal Variation in 25-Hydroxyvitamin D Concentrations in the Cardiovascular Health Study." American Journal of Epidemiology. Vol. 174, no. 12. (Dec 2011): 1363-1372.

de Boer IH, Kestenbaum B Shoben AB; et al. 2009. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. Journal American Society of Nephrology. Vol. 20, no. 8. (Aug 2009): 1805-1812.

de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS. Serum 25-hydroxyvitamin D concentration and coronary artery calcium in the Multi-Ethnic Study of Atherosclerosis. J Am Soc Nephrol, 20(8):1805-12, 2009.

Shoben AB, Rudser KD, de Boer IH; et al. 2008. Association of oral calcitriol with improved surivival in nondialized CKD. Journal American Society of Nephrology. Vol. 19, no. 8. (Aug 2008): 1613-1619.

Green Buckeye Certified CEPH CAHME